Delivering drugs directly
US scientists have developed a method of administering medication in which the drug delivery system is the drug itself.

The problem of efficiently delivering drugs, especially those that are hydrophobic, to tumours or other disease sites has long challenged scientists to develop innovative delivery systems that keep these drugs intact until reaching their targets.
Scientists in the University at
The drug delivery system consists of 100 nanometre crystals of a hydrophobic drug, HPPH, (2-devinyl-2-(1'-hexyloxyethyl) pyropheophorbide), a photosensitiser currently in Phase I/II human clinical trials at RPCI for treating various types of cancer.
The UB researchers found that the nanocrystals of HPPH were taken up by tumors in vivo, with efficacy comparable to conventional, surfactant-based delivery systems.
The nanocrystals present a major advantage over methods of delivery involving other carriers, according to chemistry professor Paras Prasad.
Because other delivery systems commonly used with HPPH and many other drugs, especially those containing surfactants, may add to the toxicity in the body, they have been considered imperfect solutions.
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Radio wave weapon knocks out drone swarms
Probably. A radio-controlled drone cannot be completely shielded to RF, else you´d lose the ability to control it. The fibre optical cable removes...